TrialChest2015

Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis.

David J Lederer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.